about
Past speculations of the future: a review of the methods used for forecasting emerging health technologiesDecline in new drug launches: myth or reality? Retrospective observational study using 30 years of data from the UKTrends in sexually transmitted infections (other than HIV) in older people: analysis of data from an enhanced surveillance system.New and emerging technologies for the diagnosis and monitoring of chronic obstructive pulmonary disease: A horizon scanning review.How innovative are new drugs launched in the UK? A retrospective study of new drugs listed in the British National Formulary (BNF) 2001-2012Effects of daily variation in outdoor particulates and ambient acid species in normal and asthmatic childrenParticulate air pollution and panel studies in children: a systematic review.New and emerging technologies for the treatment of inherited retinal diseases: a horizon scanning reviewTrends in clinical development timeframes for antiviral drugs launched in the UK, 1981-2014: a retrospective observational study.Accuracy of pharmaceutical company licensing predictions: projected versus actual licensing dates.Post-infection fatigue syndrome following Q fever.Emerging point of care tests for influenza: innovation or status quo.Innovation and the burden of disease: retrospective observational study of new and emerging health technologies reported by the EuroScan Network from 2000 to 2009.Impact of correcting peak flow for nonlinear errors on air pollutant effect estimates from a panel study.Trends in the costs of drugs launched in the UK between 1981 and 2015: an analysis of the launch price of drugs in five disease areasA syphilis outbreak: recent trends in infectious syphilis in Birmingham, UK, in 2005 and control strategies
P50
Q28076476-4B7A3A2D-B15F-4530-8068-79E85BB9C777Q30591600-D5596CD2-83D3-44A5-B2DA-CA9C7591185AQ31160831-C5E5088F-B11A-468E-936B-7AB39DB032CFQ33447633-1E286813-C5EF-4A08-A59C-CEDD63415D39Q34417204-47096D93-6B26-4FBC-BB6B-2E7914ECC246Q35535217-A087C5B2-B420-47CE-907C-F998F1F32570Q35697388-3758E1C7-B7EB-4209-A596-6C2459670EFCQ36048823-610CDD84-92F1-4222-BE77-9421AD903EBBQ36302796-A7186163-C79B-43A4-ADC6-34B7A4FF0BF1Q37252514-8AA4B603-5549-4569-83CB-7B819948C4C6Q44054455-521D6130-8DE7-436A-9303-6ECC9DB2999BQ49396437-F713273F-785A-43C7-AEF2-9C20FC2BCF87Q50764463-35E1EAF1-9A95-4039-8A45-F90CD71EBBE1Q52081625-9E6409A6-08A3-4C24-A869-9A6C40E8A5A7Q64066783-B6DC4748-B1B5-419C-9938-76CDBDBFE0DFQ80563412-84A38403-0B85-4299-AD78-CFE4B4EDE03C
P50
description
researcher ORCID ID = 0000-0003-0740-9741
@en
name
D Ward
@ast
D Ward
@en
D Ward
@nl
type
label
D Ward
@ast
D Ward
@en
D Ward
@nl
prefLabel
D Ward
@ast
D Ward
@en
D Ward
@nl
P31
P496
0000-0003-0740-9741